From January 1, 2024 to March 31, 2024, the company has repurchased 1,193,300 shares, representing 1.7% for CNY 42.79 million. With this, the company has completed the repurchase of 1,901,841 shares, representing 2.71% for CNY 73.56 million under the buyback announced on October 21, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
24.95 CNY | +0.04% | -8.54% | -11.04% |
1st Jan change | Capi. | |
---|---|---|
-11.04% | 344M | |
+51.93% | 791B | |
+40.45% | 630B | |
+17.13% | 328B | |
+9.12% | 298B | |
+17.25% | 246B | |
+0.41% | 225B | |
+10.22% | 218B | |
+4.57% | 160B | |
-6.03% | 156B |
- Stock Market
- Equities
- 301331 Stock
- News Enwei Pharmaceutical Co., Ltd.
- Tranche Update on Enwei Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 21, 2023.